Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
37K characters. Original on sec.gov ·
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
Introduction
This management's discussion and analysis ("MD&A") of financial condition and results of operations is intended to provide investors with an understanding of our recent performance, financial condition and prospects. Dollar amounts are reported in millions, except per share dollar amounts, unless otherwise noted. The following will be discussed and analyzed:
-
Overview of First Quarter 2022 Results
-
Results of Operations and Related Information
-
Liquidity and Capital Resources
-
Information Concerning Forward-Looking Statements
We describe our business outside North America in two groups – Developing and Emerging Markets ("D&E") and Developed Markets. D&E markets comprise Eastern Europe, the Middle East and Africa, Latin America and Asia-Pacific, excluding Australia and South Korea. Developed Markets consist of Western and Central Europe, Australia and South Korea. We have three reportable business segments: Personal Care, Consumer Tissue and K-C Professional. These business segments are described in greater detail in Note 7 to the unaudited interim consolidated financial statements.
On February 24, 2022, we completed our acquisition of a majority and controlling share of Thinx Inc. (“Thinx”), an industry leader in the reusable period and incontinence underwear category, for total consideration of $181 consisting of cash of $53, the fair value of our previously held equity investment of $127, and certain share-based award costs of $1.
This section presents a discussion and analysis of our first quarter 2022 net sales, operating profit and other information relevant to an understanding of the results of operations. In addition, we provide commentary regarding organic sales growth, which describes the impact of changes in volume, net selling prices and product mix on net sales. Change in foreign currency exchange rates and exited businesses also impact the year-over-year change in net sales. Our analysis compares the three months ended March 31, 2022 results to the same period in 2021.
In March 2022, we implemented significant adjustments to our business in Russia and suspended all media, advertising and promotional activity as well as capital investments in our sole manufacturing facility. Consistent with the humanitarian nature of our products, we are producing only essential items, specifically baby diapers and feminine pads, which are critical to the health and hygiene of women, girls and babies, but our ability to provide these items may change as the situation evolves. Our Russia business has historically represented approximately 1 to 2 percent of our net sales, operating profit and total assets. We are actively monitoring the situation, and as the business, geopolitical and regulatory environment concerning Russia evolves, our assets may be partially or fully impaired. For a more complete discussion of the risks we encounter in our business, please refer to Item 1A, "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2021.
Throughout this MD&A, we refer to financial measures that have not been calculated in accordance with accounting principles generally accepted in the U.S., or GAAP, and are therefore referred to as non-GAAP financial measures. These measures include adjusted gross and operating profit, adjusted net income, adjusted earnings per share, adjusted other (income) and expense, net and adjusted effective tax rate. We believe these measures provide our investors with additional information about our underlying results and trends, as well as insight into some of the financial measures used to evaluate management.
Non-GAAP financial measures are not meant to be considered in isolation or as a substitute for the comparable GAAP measures, and they should be read only in conjunction with our unaudited interim consolidated financial statements prepared in accordance with GAAP. There are limitations to these non-GAAP financial measures because they are not prepared in accordance with GAAP and may not be comparable to similarly titled measures of other companies due to potential differences in methods of calculation and items being excluded. We compensate for these limitations by using these non-GAAP financial measures as a supplement to the GAAP measures and by providing reconciliations of the non-GAAP and comparable GAAP financial measures.
The non-GAAP financial measures exclude the following item for the relevant time period as indicated in the reconciliations included later in this MD&A:
- Acquisition of controlling interest in Thinx – In the first quarter of 2022, we increased our investment in Thinx. As a result of this transaction, a net benefit was recognized of $64 pre-tax ($68 after tax), primarily due to the non-recurring, non-cash gain recognized related to the remeasurement of the carrying value of our previously held equity investment to fair value partially offset by transaction and integration costs. See Item 1, Note 2 to the unaudited interim consolidated financial statements for details.
The non-GAAP financial measures also exclude charges in 2021 for the 2018 Global Restructuring Program as indicated in the reconciliations included later in this MD&A. In 2018, we initiated this restructuring in order to reduce our structural cost base by streamlining and simplifying our manufacturing supply chain and overhead organization. As a result, we recognized restructuring charges in 2018, 2019, 2020 and 2021 for this program. Restructuring actions were completed in 2021.
Overview of First Quarter 2022 Results
-
Net sales of $5.1 billion increased 7 percent compared to the year-ago period, including organic sales growth of 10 percent.
-
Operating profit was $693 in 2022 and $770 in 2021. Net Income Attributable to Kimberly-Clark Corporation was $523 in 2022 compared to $584 in 2021, and diluted earnings per share were $1.55 in 2022 compared to $1.72 in 2021. Results in 2022 include the net benefit of the acquisition of a controlling interest of Thinx, compared to 2021 results, which include charges related to the 2018 Global Restructuring Program.
Results of Operations and Related Information
This section presents a discussion and analysis of our first quarter 2022 net sales, operating profit and other information relevant to an understanding of the results of operations.
Consolidated
| Selected Financial Results | Three Months Ended March 31 | ||||||||||||||||||||||||||||||||||
| 2022 | 2021 | Percent Change | |||||||||||||||||||||||||||||||||
| Net Sales: | |||||||||||||||||||||||||||||||||||
| North America | $ | 2,614 | $ | 2,351 | +11 | % | |||||||||||||||||||||||||||||
| Outside North America | 2,546 | 2,470 | +3 | % | |||||||||||||||||||||||||||||||
| Intergeographic sales | (65) | (78) | -17 | % | |||||||||||||||||||||||||||||||
| Total Net Sales | 5,095 | 4,743 | +7 | % | |||||||||||||||||||||||||||||||
| Operating Profit: | |||||||||||||||||||||||||||||||||||
| North America | 459 | 508 | -10 | % | |||||||||||||||||||||||||||||||
| Outside North America | 277 | 367 | -25 | % | |||||||||||||||||||||||||||||||
| Corporate & Other(a) | (102) | (101) | N.M. | ||||||||||||||||||||||||||||||||
| Other (income) and expense, net(a) | (59) | 4 | N.M. | ||||||||||||||||||||||||||||||||
| Total Operating Profit | 693 | 770 | -10 | % | |||||||||||||||||||||||||||||||
| Share of net income of equity companies | 23 | 39 | -41 | % | |||||||||||||||||||||||||||||||
| Net Income Attributable to Kimberly-Clark Corporation | 523 | 584 | -10 | % | |||||||||||||||||||||||||||||||
| Diluted Earnings per Share | 1.55 | 1.72 | -10 | % |
(a) Corporate & Other and Other (income) and expense, net include income and expense not associated with the business segments, including adjustments as indicated in the Non-GAAP Reconciliations.
N.M. - Not Meaningful
GAAP to Non-GAAP Reconciliations of Selected Financial Results
| Three Months Ended March 31, 2022 | ||||||||||||||||||||||||||
| As Reported | Acquisition of Controlling Interest in Thinx | As Adjusted Non-GAAP | ||||||||||||||||||||||||
| Marketing, research and general expenses | $ | 886 | $ | 21 | $ | 865 | ||||||||||||||||||||
| Other (income) and expense, net | (59) | (85) | 26 | |||||||||||||||||||||||
| Operating Profit | 693 | 64 | 629 | |||||||||||||||||||||||
| Provision for income taxes | (114) | 4 | (118) | |||||||||||||||||||||||
| Effective tax rate | 18.2 | % | — | 21.0 | % | |||||||||||||||||||||
| Net Income Attributable to Kimberly-Clark Corporation | 523 | 68 | 455 | |||||||||||||||||||||||
| Diluted Earnings per Share(a) | 1.55 | 0.20 | 1.35 |
| Three Months Ended March 31, 2021 | ||||||||||||||||||||||||||
| As Reported | 2018 Global Restructuring Program | As Adjusted Non-GAAP | ||||||||||||||||||||||||
| Cost of products sold | $ | 3,154 | $ | 25 | $ | 3,129 | ||||||||||||||||||||
| Gross Profit | 1,589 | (25) | 1,614 | |||||||||||||||||||||||
| Marketing, research and general expenses | 815 | 9 | 806 | |||||||||||||||||||||||
| Operating Profit | 770 | (34) | 804 | |||||||||||||||||||||||
| Provision for income taxes | (147) | 7 | (154) | |||||||||||||||||||||||
| Effective tax rate | 20.9 | % | — | 20.9 | % | |||||||||||||||||||||
| Net income attributable to noncontrolling interests | (10) | 1 | (11) | |||||||||||||||||||||||
| Net Income Attributable to Kimberly-Clark Corporation | 584 | (26) | 610 | |||||||||||||||||||||||
| Diluted Earnings per Share(a) | 1.72 | (0.08) | 1.80 |
(a) "As Adjusted Non-GAAP" may not equal "As Reported" plus "Adjustments" as a result of rounding.
Analysis of Consolidated Results
| Net Sales | Percent Change for Three Months Ended March 31, 2022 | Adjusted Operating Profit | Percent Change for Three Months Ended March 31, 2022 | |||||||||||||||||||||||||||||
| Volume | 2 | Volume | (2) | |||||||||||||||||||||||||||||
| Net Price | 6 | Net Price | 37 | |||||||||||||||||||||||||||||
| Mix/Other | 2 | Input Costs | (58) | |||||||||||||||||||||||||||||
| Currency | (2) | Cost Savings(c) | 6 | |||||||||||||||||||||||||||||
| Total(a) | 7 | Currency Translation | (2) | |||||||||||||||||||||||||||||
| Other(d) | (3) | |||||||||||||||||||||||||||||||
| Organic(b) | 10 | Total | (22) |
(a) Total may not equal the sum of volume, net price, mix/other and currency due to rounding.
(b) Combined impact of changes in volume, net price and mix/other.
(c) Benefits of the FORCE (Focused On Reducing Costs Everywhere) program.
(d) Includes impact of changes in product mix, marketing, research and general expenses, foreign currency transaction effects and other manufacturing costs.
Net sales in the first quarter of $5.1 billion increased 7 percent compared to the year-ago period. Changes in foreign currency exchange rates reduced sales by 2 percent. Organic sales increased 10 percent as changes in net selling prices increased sales by 6 percent, volumes grew 2 percent and changes in product mix increased sales by 2 percent.
In North America, organic sales increased 13 percent in consumer products and increased 5 percent in K-C Professional. Outside North America, organic sales rose 10 percent in D&E markets and 8 percent in developed markets.
Operating profit in the first quarter was $693 in 2022 and $770 in 2021. Results in 2022 include the net benefit of the acquisition of a controlling interest in Thinx, compared to 2021 results which include charges related to the 2018 Global
Restructuring Program. First quarter adjusted operating profit was $629 in 2022 and $804 in 2021. Results were impacted by $470 of higher input costs, driven by pulp and polymer-based materials, distribution and energy costs. Higher marketing, research and general expense as well as the impact of unfavorable foreign currency transaction effects reduced operating profit in the quarter. Results benefited from organic sales growth, $50 of cost savings from our FORCE program and lower other manufacturing costs.
The first quarter effective tax rate was 18.2 percent in 2022 and 20.9 percent in 2021. The first quarter adjusted effective tax rate was 21.0 percent in 2022 and 20.9 percent in 2021.
Our share of net income of equity companies in the first quarter was $23 in 2022 and $39 in 2021. Equity results were negatively impacted by input cost inflation.
Diluted net income per share for the first quarter of 2022 was $1.55 and $1.72 in 2021. First quarter adjusted earnings per share were $1.35 in 2022, a decrease of 25 percent compared to $1.80 in 2021.
Results by Business Segments
Personal Care
| Three Months Ended March 31 | Three Months Ended March 31 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net Sales | $ | 2,729 | $ | 2,462 | Operating Profit | $ | 475 | $ | 481 | |||||||||||||||||||||||||||||||||||||||||||||||
| Net Sales | Percent Change | Operating Profit | Percent Change | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Volume | 3 | Volume | 1 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net Price | 8 | Net Price | 40 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mix/Other | 3 | Input Costs | (44) | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Currency | (2) | Cost Savings(c) | 5 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total(a) | 11 | Currency Translation | (3) | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other(d) | — | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Organic(b) | 13 | Total | (1) |
(a) Total may not equal the sum of volume, net price, mix/other and currency due to rounding.
(b) Combined impact of changes in volume, net price and mix/other.
(c) Benefits of the FORCE program.
(d) Includes impact of changes in product mix, marketing, research and general expenses, foreign currency transaction effects and other manufacturing costs.
First quarter net sales in North America increased 16 percent. Changes in net selling prices and product mix increased sales by 8 percent and 3 percent, respectively. Volumes rose 5 percent, in part due to the weather-related supply chain disruptions in the year-ago period. Organic sales were up double-digits in baby & child care, adult care and feminine care.
Net sales in D&E markets increased 8 percent. Changes in net selling prices and product mix increased sales by 9 percent and 3 percent, respectively, while volumes declined 1 percent. Changes in foreign currency exchange rates decreased sales by 3 percent. Organic sales growth was strong across all regions and categories.
Net sales in developed markets outside North America increased 5 percent. Volumes increased 8 percent and changes in net selling prices increased sales by 4 percent, while changes in foreign currency exchange rates decreased sales by 7 percent.
Operating profit of $475 decreased 1 percent. The comparison was impacted by input cost inflation, higher marketing, research and general expense as well as unfavorable foreign currency effects. Results benefited from organic sales growth and cost savings.
Consumer Tissue
| Three Months Ended March 31 | Three Months Ended March 31 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net Sales | $ | 1,568 | $ | 1,510 | Operating Profit | $ | 171 | $ | 269 | |||||||||||||||||||||||||||||||||||||||||||||||
| Net Sales | Percent Change | Operating Profit | Percent Change | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Volume | 2 | Volume | (1) | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net Price | 5 | Net Price | 26 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mix/Other | — | Input Costs | (66) | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Exited businesses(e) | (1) | Cost Savings(c) | 7 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Currency | (2) | Currency Translation | — | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total(a) | 4 | Other(d) | (2) | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Organic(b) | 7 | Total | (36) | |||||||||||||||||||||||||||||||||||||||||||||||||||||
(a) Total may not equal the sum of volume, net price, mix/other, exited businesses and currency due to rounding.
(b) Combined impact of changes in volume, net price and mix/other.
(c) Benefits of the FORCE program.
(d) Includes impact of changes in marketing, research and general expenses, foreign currency transaction effects and other manufacturing costs.
(e) Impact of exited businesses in conjunction with the 2018 Global Restructuring Program.
First quarter net sales in North America increased 9 percent. Volumes grew 6 percent and changes in net selling prices increased sales by 4 percent, while unfavorable changes in product mix decreased sales by 1 percent. The volume growth reflects comparison to the start of COVID-related consumer and retailer inventory destocking in the year-ago period.
Net sales in D&E markets increased 3 percent. Changes in net selling prices increased sales by approximately 7 percent and changes in product mix increased sales by 1 percent, while volumes were down 2 percent. Changes in foreign currency exchange rates decreased sales by 2 percent.
Net sales in developed markets outside North America decreased 5 percent. Exited businesses related to the 2018 Global Restructuring program reduced sales by 4 percent, and changes in foreign currency exchange rates decreased sales by 6 percent. Volumes were down 1 percent, while changes in net selling prices increased sales by approximately 6 percent.
Operating profit of $171 decreased 36 percent. The comparison was impacted by input cost inflation and higher marketing, research and general expense. Results benefited from organic sales growth, lower other manufacturing costs and cost savings.
K-C Professional
| Three Months Ended March 31 | Three Months Ended March 31 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net Sales | $ | 780 | $ | 752 | Operating Profit | $ | 90 | $ | 126 | |||||||||||||||||||||||||||||||||||||||||||||||
| Net Sales | Percent Change | Operating Profit | Percent Change | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Volume | — | Volume | (13) | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net Price | 4 | Net Price | 25 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mix/Other | 1 | Input Costs | (63) | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Currency | (2) | Cost Savings(c) | 6 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total(a) | 4 | Currency Translation | (1) | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other(d) | 17 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Organic(b) | 6 | Total | (29) |
(a) Total may not equal the sum of volume, net price, mix/other and currency due to rounding.
(b) Combined impact of changes in volume, net price and mix/other.
(c) Benefits of the FORCE program.
(d) Includes impact of changes in product mix, marketing, research and general expenses, foreign currency transaction effects and other manufacturing costs.
First quarter net sales in North America increased 5 percent. Changes in net selling prices and product mix increased sales by 4 percent and 1 percent, respectively. Washroom products sales were up strong double-digits, while sales of wipers and safety products slowed versus a strong year-ago.
Net sales in D&E markets increased 4 percent. Changes in net selling prices and product mix increased sales by 3 percent and 2 percent, respectively, and volumes grew by 2 percent. Changes in foreign currency exchange rates decreased sales by 3 percent.
Net sales in developed markets outside North America were even with the year-ago period. Changes in net selling prices and product mix increased sales by 5 percent and 3 percent, respectively, while volumes decreased 1 percent. Changes in foreign currency exchange rates reduced sales by 7 percent.
Operating profit of $90 decreased 29 percent. The comparison was impacted by input cost inflation and higher marketing, research and general expense. Results benefited from organic sales growth, lower other manufacturing costs and cost savings.
Liquidity and Capital Resources
Cash Provided by Operations
Cash provided by operations was $204 for the first three months of 2022 compared to $321 in the prior year. The decline was driven by lower operating profit.
Investing
During the three months ended March 31, 2022, our capital spending was $253 compared to $298 in the prior year. We anticipate that full year capital spending will be $1.0 billion to $1.1 billion. Acquisition of business, net of cash acquired of $34 in the first quarter of 2022 reflected the acquisition of a controlling interest of Thinx.
Financing
Our short-term debt, which consists of U.S. commercial paper with original maturities up to 90 days and/or other similar short-term debt issued by non-U.S. subsidiaries, was $1.0 billion as of March 31, 2022 (included in Debt payable within one year on the consolidated balance sheet). The average month-end balance of short-term debt for the first quarter of 2022 was $0.9 billion. These short-term borrowings provide supplemental funding to support our operations. The level of short-term debt generally fluctuates depending upon the amount of operating cash flows and the timing of customer receipts and payments for items such as dividends and income taxes.
At March 31, 2022 and December 31, 2021, total debt was $9.1 billion and $8.6 billion, respectively.
We maintain a $2.0 billion revolving credit facility which expires in June 2026 and a $750 revolving credit facility which expires in June 2022. These facilities, currently unused, support our commercial paper program, and would provide liquidity in the event our access to the commercial paper markets is unavailable for any reason.
The United Kingdom’s Financial Conduct Authority, which regulates the London Interbank Offered Rate (“LIBOR”), is in the process of phasing out LIBOR with completion of the phase out expected by June 30, 2023. We have evaluated the potential effect of the elimination of LIBOR and do not expect the effect to be material. Accounting guidance has been issued to ease the transition to alternative reference rates from a financial reporting perspective.
We repurchase shares of Kimberly-Clark common stock from time to time pursuant to publicly announced share repurchase programs. During the first three months of 2022, we repurchased 214 thousand shares of our common stock at a cost of $27 through a broker in the open market. We are targeting full-year 2022 share repurchases of approximately $100, subject to market conditions.
We believe that our ability to generate cash from operations and our capacity to issue short-term and long-term debt are adequate to fund working capital, capital spending, pension contributions, dividends and other needs for the foreseeable future. Further, we do not expect restrictions or taxes on repatriation of cash held outside of the U.S. to have a material effect on our overall business, liquidity, financial condition or results of operations for the foreseeable future.
Information Concerning Forward-Looking Statements
Certain matters contained in this report concerning the business outlook, including raw material, energy and other input costs, the anticipated cost savings from our FORCE program, cash flow and uses of cash, growth initiatives, innovations, marketing and other spending, net sales, anticipated currency rates and exchange risks, including the impact in Argentina, effective tax rate, contingencies and anticipated transactions of Kimberly-Clark, including dividends, share repurchases and pension contributions, constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of
1995 and are based upon management's expectations and beliefs concerning future events impacting Kimberly-Clark. There can be no assurance that these future events will occur as anticipated or that our results will be as estimated. Forward-looking statements speak only as of the date they were made, and we undertake no obligation to publicly update them.
The assumptions used as a basis for the forward-looking statements include many estimates that, among other things, depend on the achievement of future cost savings and projected volume increases. In addition, many factors outside our control, including the war in Ukraine (including the related responses of consumers, customers, and suppliers and sanctions issued by the U.S., the European Union, Russia or other countries), pandemics (including the ongoing COVID-19 outbreak and the related responses of governments, consumers, customers, suppliers and employees), epidemics, fluctuations in foreign currency exchange rates, the prices and availability of our raw materials, supply chain disruptions, changes in customer preferences, severe weather conditions, government trade or similar regulatory actions, potential competitive pressures on selling prices for our products, energy costs, general economic and political conditions globally and in the markets in which we do business, as well as our ability to maintain key customer relationships, could affect the realization of these estimates.
The factors described under Item 1A, "Risk Factors" in this Form 10-K, or in our other SEC filings, among others, could cause our future results to differ from those expressed in any forward-looking statements made by us or on our behalf. Other factors not presently known to us or that we presently consider immaterial could also affect our business operations and financial results.
Previous: Item 1. Financial Statements · Next: Item 4. Controls and Procedures